Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 19, Issue 3, Pages 368-371
Publisher
Springer Nature
Online
2013-02-04
DOI
10.1038/nm.3078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
- (2012) Smita Bhatia et al. JOURNAL OF CLINICAL ONCOLOGY
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation
- (2011) N. Gokbuget et al. BLOOD
- Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia
- (2011) Jana Hof et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
- (2011) Emmanuelle Clappier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ETV6mutations in early immature human T cell leukemias
- (2011) Pieter Van Vlierberghe et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- BRAFMutations in Hairy-Cell Leukemia
- (2011) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- SDM--a server for predicting effects of mutations on protein stability and malfunction
- (2011) C. L. Worth et al. NUCLEIC ACIDS RESEARCH
- Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
- (2010) Gesche Tallen et al. JOURNAL OF CLINICAL ONCOLOGY
- I-TASSER: a unified platform for automated protein structure and function prediction
- (2010) Ambrish Roy et al. Nature Protocols
- WT1 mutations in T-ALL
- (2009) V. Tosello et al. BLOOD
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
- (2009) Elaine Coustan-Smith et al. LANCET ONCOLOGY
- Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984–2001: a report from the children's oncology group
- (2009) W L Salzer et al. LEUKEMIA
- Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
- (2009) A Möricke et al. LEUKEMIA
- Nelarabine
- (2008) Mark Sanford et al. DRUGS
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started